SILENCE THERAP. SP.ADR/1 (XRP2) — Defensive Interval Ratio
SILENCE THERAP. SP.ADR/1 (XRP2) has a Defensive Interval Ratio of 1980 days as of December 2025. Defensive assets of €73.84 Million (cash €-, short-term investments €73.84 Million, receivables €0.00) cover 1980 days of daily cash needs of €37.30K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
SILENCE THERAP. SP.ADR/1 Defensive Interval Ratio (2021–2025)
This chart shows how SILENCE THERAP. SP.ADR/1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 1980 days, meaning defensive assets of €73.84 Million can fund 1980 days of operations without new revenue. For the complete balance sheet picture, see XRP2 current and non-current assets.
Annual Defensive Interval Ratio for SILENCE THERAP. SP.ADR/1 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for SILENCE THERAP. SP.ADR/1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See SILENCE THERAP. SP.ADR/1 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1980 days | €73.84 Million | €37.30K/day | €- | €73.84 Million | ▲ +1394 days |
| 2024 | 585 days | €26.98 Million | €46.09K/day | €- | €26.00 Million | ▲ +581 days |
| 2023 | 5 days | €290.00K | €61.19K/day | €- | €0.00 | ▼ -282 days |
| 2022 | 287 days | €20.87 Million | €72.75K/day | €- | €19.76 Million | ▲ +279 days |
| 2021 | 8 days | €446.73K | €56.08K/day | €- | €0.00 | — |